Category: 2019

Cannabis Excelsior: Remembering Doug Greene

Doug was a passionate advocate for ending America’s failed war on cannabis consumers, and his work with NORML and for the cause spans decades not years. This is a sad loss for his friends and family, the New York cannabis community, and the legalization movement.

FDA Hearing On ‘Hemp-Derived CBD’ Today

In its written testimony, NORML Deputy Director Paul Armentano encourages the agency to act expeditiously to clarify confusion among both consumers and regulators with regard to the legality of specific CBD products. It further recommends that the FDA provide regulatory guidelines governing product manufacturing, standardization, and quality.